NCT04729712

Brief Summary

Minimally Invasive Thoracic Surgery (MITS) is a surgical method used to perform lung surgery through small incisions between the ribs and includes both Video-Assisted Thoracic Surgery (VATS) and Robotic assisted Thoracic Surgery (RATS). MITS can cause a significant amount of postoperative pain and if this is not adequately controlled, it can delay the patient's recovery and it may be a precipitating factor for the development of Chronic Persistent Surgical Pain (CPSP). Regional anaesthesia is the use of nerve numbing medications known as local anaesthetics to block sensations of pain from a specific area of the body. For MITS, blocking pain arising from the chest wall/rib cage would improve the patient's recovery after the operation and overall patient satisfaction. There have been significant advancements made in thoracic (chest wall) regional anaesthesia techniques. Ultimately, this involves injecting local anaesthetics around the nerves that supply the chest wall. A single injection of these medications will only have a maximum effect for up to 12 hours and often this is considerably less. To prolong the pain free benefit, a thin tube known as a catheter will be placed so that the local anaesthesia medication can be continuously given by a specific mechanical pump designed for this purpose. This mechanical pump will be located at the patient's bedside and can precisely deliver the medication in question at a rate between 10-15 ml/hr. This infusion of local anaesthesia medication will continue for 48 hours after the operation and will be monitored by the hospital's pain team. The primary aim of this study is to compare the efficacy of two techniques for thoracic regional anaesthesia after this type of surgery. Participants will be randomly assigned (like tossing a coin) to receive either an Anaesthesiologist ultrasound guided Erector Spinae Plane Block (ESP) with catheter insertion or surgeon video-assisted Paravertebral block (PVB) with catheter insertion. Both these regional anaesthesia techniques are well established in clinical practice, but there is little evidence published comparing them for this type of surgery, in terms of quality of patient's short term (1-2 days) and longer-term (3 months) recovery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 28, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

May 12, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2022

Completed
Last Updated

May 20, 2022

Status Verified

May 1, 2022

Enrollment Period

9 months

First QC Date

January 25, 2021

Last Update Submit

May 18, 2022

Conditions

Keywords

Regional AnesthesiaErector Spinae BlockThoracic Paravertebral BlockQuality of RecoveryChronic Persistent Surgical Pain

Outcome Measures

Primary Outcomes (1)

  • Quality of Recovery (QoR-15) score between Anaesthesiologist-administered ultrasound guided Erector Spinae block and Surgeon-administered video-assisted Paravertebral block at 24 hours postoperative.

    QoR-15 is a 15-parameter questionnaire which has been recommended as an optimum tool to evaluate overall patient recovery after surgery and this includes postoperative pain. Participants will complete this questionnaire at 24 hours after their surgery. It is scored between 0 and 150, where 150 indicates that the patient has had an excellent recovery.

    24 hours postoperative

Secondary Outcomes (10)

  • Chronic Persistent Surgical Pain (CPSP) after Minimally Invasive Thoracic Surgery (MITS)

    3 months postoperative

  • Chronic Persistent Surgical Pain (CPSP) after Minimally Invasive Thoracic Surgery (MITS)

    3 months postoperative

  • Pulmonary Function Assessment

    Preoperatively (day 0), postoperative day 1 and postoperative day 2

  • Area Under the Curve (AUC) of Verbal Rating Score (VRS) for pain at rest and on deep inspiration versus time over 48 hours

    48 hours postoperative

  • Time of administration of first intravenous opioid

    48 hours postoperative

  • +5 more secondary outcomes

Study Arms (2)

Anaesthesiologist-administered ultrasound guided Erector Spinae block with catheter insertion

ACTIVE COMPARATOR

Patient's will be randomised to this arm of the study. This group will receive an erector spinae block with catheter insertion under ultrasound guidance under general anaesthesia. This regional anaesthesia procedure will be performed by an Anaesthesiologist with experience in performing this block.

Procedure: Anaesthesiologist-administered ultrasound guided Erector Spinae block with catheter insertion

Surgeon-administered video-assisted Paravertebral block with catheter insertion

EXPERIMENTAL

Patient's will be randomised to this arm of the study. This group will receive a paravertebral block with catheter insertion under under thoracoscopic guidance. This regional anaesthesia procedure will be performed at the start of the operation by a surgeon with experience in performing this block.

Procedure: Surgeon-administered video-assisted Paravertebral block with catheter insertion

Interventions

Erector Spinae block: A bolus of 20 ml 0.375% Levobupivacaine will be administered into the erector spinae plane prior to surgical incision. A further bolus of 10 ml 0.25% Levobupivacaine will be given at skin closure if it has been greater than 1 hour after the first bolus of local anaesthetic medication. A continuous infusion of 0.125% Levobupivacaine will be commenced via the sited nerve catheter for postoperative analgesia. This will be started at 10 ml/hr and titrated to effect to a maximum rate of 15 ml/hr.

Anaesthesiologist-administered ultrasound guided Erector Spinae block with catheter insertion

Paravertebral block: A bolus of 20 ml 0.375% Levobupivacaine will be administered into the paravertebral space after the thoracoscopic ports have been sited. A further bolus of 10 ml 0.25% Levobupivacaine will be given at skin closure if it has been greater than 1 hour after the first bolus of local anaesthetic medication. A continuous infusion of 0.125% Levobupivacaine will be commenced via the sited nerve catheter for postoperative analgesia. This will be started at 10 ml/hr and titrated to effect to a maximum rate of 15 ml/hr.

Surgeon-administered video-assisted Paravertebral block with catheter insertion

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and Female participants providing written informed consent
  • American Society of Anesthesiologist grade 1-4
  • Unilateral MITS (VATS and RATS) under general anaesthesia

You may not qualify if:

  • Absence of written consent
  • Unexpected conversion of MITS to open thoracotomy
  • Contraindications to peripheral regional anaesthesia block: (Infection at local site, allergy to local anaesthesia medications, patient refusal, previous or existing neurological deficit, anticoagulated patients)
  • Known dementia at time of MITS and inability to give informed consent
  • Unexpected post-operative admission to ICU for continued ventilation
  • History of opioid abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Mater Misericordiae University Hospital

Dublin, D07 R2WY, Ireland

Location

St Jame's University Hospital

Dublin, D08 NHy1, Ireland

Location

Related Publications (2)

  • Moorthy A, Ni Eochagain A, Dempsey E, Wall V, Marsh H, Murphy T, Fitzmaurice GJ, Naughton RA, Buggy DJ. Postoperative recovery with continuous erector spinae plane block or video-assisted paravertebral block after minimally invasive thoracic surgery: a prospective, randomised controlled trial. Br J Anaesth. 2023 Jan;130(1):e137-e147. doi: 10.1016/j.bja.2022.07.051. Epub 2022 Sep 13.

  • Moorthy A, Eochagain AN, Dempsey E, Buggy D. Ultrasound-guided erector spinae plane catheter versus video-assisted paravertebral catheter placement in minimally invasive thoracic surgery: comparing continuous infusion analgesic techniques on early quality of recovery, respiratory function and chronic persistent surgical pain: study protocol for a double-blinded randomised controlled trial. Trials. 2021 Dec 28;22(1):965. doi: 10.1186/s13063-021-05863-9.

MeSH Terms

Conditions

Pain, PostoperativeChronic Pain

Interventions

Catheterization

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsInvestigative Techniques

Study Officials

  • Donal Buggy, MB Bch BAO

    Professor of Anaesthesiology & Perioperative Medicine, Mater Misericordiae University Hospital,

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The erector spinae plane and paravertebral blocks with catheter insertion will be performed after induction of general anaesthesia and therefore participants will be blinded to which intervention they have had. The outcome assessors for this study will be unaware as to which group the participant will be randomised to and therefore they will be blinded to which intervention the participant had received.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This will be a multicentre, prospective, double-blinded, randomised controlled clinical trial. This study will take place between three level four academic hospitals in Co.Dublin, Ireland. One group will receive an Anaesthesiologist-administered, ultrasound guided erector spinae plane catheter and the other group will receive a surgeon-administered, video-assisted paravertebral catheter.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Fellow in Anaesthesia and Perioperative Medicine

Study Record Dates

First Submitted

January 25, 2021

First Posted

January 28, 2021

Study Start

May 12, 2021

Primary Completion

February 10, 2022

Study Completion

May 5, 2022

Last Updated

May 20, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will share

Individual Patient Data sharing will be supported with qualified external researchers and supporting clinical documents from eligible studies. All data provided will be coded and anonymised to respect the privacy of patients who have participated in the trial.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
5 years
Access Criteria
Publications, reports or query requests from future investigators.

Locations